Skip to content
Home/Companies/Healthcare/Torbay Pharmaceuticals
Torbay Pharmaceuticals

Torbay Pharmaceuticals

Healthcare·UK·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Torbay Pharmaceuticals?

Torbay Pharmaceuticals is currently owned by NorthEdge Capital through NorthEdge Fund III (2020 vintage), since 2023.

Hand-verified · updated 2026-04-21

NorthEdge Capital
Investor
NorthEdge Capital
NorthEdge Fund III · 2020 · Buyout

Key facts

HQUK
SectorHealthcare
Websitetorbaypharma.com

More from NorthEdge Fund III

Other portfolio companies in the same fund.

Oak Engage
Oak Engage
Active
SaaSUK· 2025
Contollo
Contollo
Active
Business ServicesUK· 2024
Latus Group
Latus Group
Active
HealthcareUK· 2024
PebblePad
PebblePad
Active
EdTechUK· 2024
RoukenBio
Active
BiotechUK· 2023
Friend MTS
Friend MTS
Active
CybersecurityUK· 2022

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Torbay Pharmaceuticals

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Torbay Pharmaceuticals.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue